Chemed Corp (CHE): Price and Financial Metrics

Chemed Corp (CHE)

Today's Latest Price: $422.94 USD

22.36 (5.58%)

Updated Apr 2 1:23pm

Add CHE to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 66 in Medical - Services

See all "A" rated Strong Buy stocks

CHE Stock Summary

  • With a one year PEG ratio of 305.07, Chemed Corp is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 90.06% of US stocks.
  • Chemed Corp's stock had its IPO on January 1, 1986, making it an older stock than 92.67% of US equities in our set.
  • The volatility of Chemed Corp's share price is greater than that of just 8.19% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to Chemed Corp, a group of peers worth examining would be MDC, NVEE, JOBS, NCBS, and FSS.
  • CHE's SEC filings can be seen here. And to visit Chemed Corp's official web site, go to
CHE Daily Price Range
CHE 52-Week Price Range

CHE Stock Price Chart More Charts

CHE Price/Volume Stats

Current price $422.94 52-week high $513.75
Prev. close $400.58 52-week low $313.49
Day low $394.47 Volume 37,750
Day high $434.10 Avg. volume 110,160
50-day MA $441.34 Dividend yield 0.32%
200-day MA $421.86 Market Cap 6.79B

Chemed Corp (CHE) Company Bio

Chemed Corporation provides hospice and palliative care services in the United States. It operates through two segments, VITAS and Roto-Rooter. The company offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. It also provides plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers. The company was founded in 1970 and is based in Cincinnati, Ohio.

CHE Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Chemed Corp. To summarize, we found that Chemed Corp ranked in the 38th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. In terms of the factors that were most noteworthy in this DCF analysis for CHE, they are:

  • Interest coverage, a measure of earnings relative to interest payments, is 58.69; that's higher than 91.24% of US stocks in the Healthcare sector that have positive free cash flow.
  • The business' balance sheet reveals debt to be 2% of the company's capital (with equity being the remaining amount). Approximately only 6.85% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
  • CHE's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 61.26% of tickers in our DCF set.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as CHE, try MCK, MDT, MD, PBH, and AMED.

CHE Latest News Stream

Event/TimeNews Detail
Loading, please wait...

CHE Latest Social Stream

Loading social stream, please wait...

View Full CHE Social Stream

CHE Price Returns

1-mo -2.24%
3-mo -4.10%
6-mo 2.69%
1-year 30.55%
3-year 132.92%
5-year 263.42%
YTD -3.65%
2019 55.58%
2018 17.01%
2017 52.32%
2016 7.89%
2015 42.74%

CHE Dividends

Ex-Dividend DateTypePayout AmountChange
Loading, please wait...
View Full CHE Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8685 seconds.